Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Do pre-existing antibodies alter the development of memory B cells in response to SARS-CoV-2 mRNA vaccination in humans?

Researchers explored how passive administration of monoclonal antibodies impact the development of immunological memory in response to COVID-19 vaccination.

15 Aug 2022

Superior protection with 'mix-and-match' COVID-19 booster strategy

Researchers discuss the durability and immunogenicity of homologous and heterologous booster regimens.

14 Aug 2022

In monkeys, spike-based vaccines produce some immunity based on CD8 T-cells

Scientists evaluate the role of CD8+ T-cells in vaccine protection against SARS-CoV-2 infection in rhesus macaques.

14 Aug 2022

How well does hybrid immunity protect against SARS-CoV-2 and its variants?

A new study explores the protection elicited by hybrid immunity against SARS-CoV-2 variants.

14 Aug 2022

Why is COVID-19 more severe in people older than 50?

A new study reports that the reduced efficiency of the immune response against SARS-CoV-2 could be due to the reduced diversity of both B- and T-cells.

14 Aug 2022

Mechanistic insights into engineered ACE2 receptor traps

Researchers determined the cryo-electron microscopic (cryo-EM) structures of engineered angiotensin-converting enzyme 2 (ACE2) receptor traps.

12 Aug 2022

Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages

In a new study, researchers developed bispecific-antibodies (bsAbs) against SARS-CoV-2 Omicron sub-lineages.

12 Aug 2022

What is the genomic diversity of SARS-CoV-2 infections in households?

In a new study, researchers assessed the genomic diversity of SARS-CoV-2 in households.

12 Aug 2022

Influence of SARS-CoV-2 breakthrough infection and age on humoral immunity post-three-dose COVID-19 vaccination

In a new study, researchers briefly reported the effect of SARS-CoV-2 breakthrough infection and age on humoral immunity following triple-dose SARS-CoV-2 messenger ribonucleic acid (mRNA) vaccination.

12 Aug 2022

What are the unique traits of Long COVID?

In a new study, researchers identified distinctive characteristics of post-acute sequelae of COVID-19 (PASC) via immune profiling.

12 Aug 2022

What is the impact of COVID-19 on male reproductive health?

In a recent study, researchers assessed male reproductive health three months after COVID-19 infection.

12 Aug 2022

Depression may be the strongest predictor of COVID-19-associated persistent brain fog, study finds

In a new study, researchers assessed the prevalence of cognitive complaints in COVID-19 patients and explored the factors associated with brain fog after one year of COVID-19 diagnosis.

12 Aug 2022

How is artificial intelligence used in COVID-19 research?

A new study discussed the roles of artificial intelligence (AI) in combating the COVID-19 pandemic.

12 Aug 2022

Experts urge FDA to include T cell responses when evaluating COVID vaccines

Now, a group of prominent scientists and physicians are urging the FDA to include in its guidance to vaccine developers a recommendation for T-cell assessment in COVID-19 vaccine clinical trials to more comprehensively measure immune response.

11 Aug 2022

How does COVID-19 increase clotting risk?

An in-depth review article describing coronavirus disease 2019 (COVID-19)-related coagulopathy has recently been published in the journal Nature Reviews Immunology.

11 Aug 2022

Study highlights the urgent need for combinatorial drug therapies for SARS-CoV-2

Researchers investigated the susceptibility of naturally-occurring severe acute respiratory syndrome coronavirus 2 main protease variants to protease inhibitor drugs, including nirmatrelvir and ensitrelvir.

11 Aug 2022

Assessment of replicon ribonucleic acid COVID-19 vaccine in nonhuman primates

Researchers explored the immunogenicity of a replicon ribonucleic acid (repRNA) COVID-19 vaccine, repRNA-CoV2S, in pigtail macaques.

11 Aug 2022

Study identifies multiple pathways adopted by SARS-CoV-2 to develop resistance to nirmatrelvir

Researchers demonstrated multiple routes SARS-CoV-2 might take to develop high-level resistance to nirmatrelvir, an oral antiviral targeting the 3C-like protease (3CLpro) of SARS-CoV-2.

11 Aug 2022

Gut microbial and immune parameters linked to heterogeneous inter-personal COVID-19 vaccine-triggered immunity

A new study identified the gut microbial and immune variables linked to heterogeneous messenger ribonucleic acid (mRNA) COVID-19 vaccine responses between individuals.

11 Aug 2022

SARS-CoV-2 receptor-binding domain-based protein subunit vaccine shows promise against multiple SARS-CoV-2 variants

Researchers described a novel protein subunit vaccine comprising the receptor-binding domain (RBD) of ancestral SARS-CoV-2 spike (S) protein, dimerized with an immunoglobulin (Ig)G1-fraction, crystallizable (Fc) domain.

11 Aug 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Do pre-existing antibodies alter the development of memory B cells in response to SARS-CoV-2 mRNA vaccination in humans?

Superior protection with 'mix-and-match' COVID-19 booster strategy

In monkeys, spike-based vaccines produce some immunity based on CD8 T-cells

How well does hybrid immunity protect against SARS-CoV-2 and its variants?

Why is COVID-19 more severe in people older than 50?

Mechanistic insights into engineered ACE2 receptor traps

Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages

What is the genomic diversity of SARS-CoV-2 infections in households?

Influence of SARS-CoV-2 breakthrough infection and age on humoral immunity post-three-dose COVID-19 vaccination

What are the unique traits of Long COVID?

What is the impact of COVID-19 on male reproductive health?

Depression may be the strongest predictor of COVID-19-associated persistent brain fog, study finds

How is artificial intelligence used in COVID-19 research?

Experts urge FDA to include T cell responses when evaluating COVID vaccines

How does COVID-19 increase clotting risk?

Study highlights the urgent need for combinatorial drug therapies for SARS-CoV-2

Assessment of replicon ribonucleic acid COVID-19 vaccine in nonhuman primates

Study identifies multiple pathways adopted by SARS-CoV-2 to develop resistance to nirmatrelvir

Gut microbial and immune parameters linked to heterogeneous inter-personal COVID-19 vaccine-triggered immunity

SARS-CoV-2 receptor-binding domain-based protein subunit vaccine shows promise against multiple SARS-CoV-2 variants

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in